Compare SLNG & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLNG | STIM |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.0M | 120.4M |
| IPO Year | 2019 | 2018 |
| Metric | SLNG | STIM |
|---|---|---|
| Price | $5.35 | $2.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $10.00 | $3.00 |
| AVG Volume (30 Days) | 38.8K | ★ 1.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2400.00 | 57.25 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $68,245,000.00 | $52,776,000.00 |
| Revenue This Year | $8.66 | $11.10 |
| Revenue Next Year | $14.31 | $11.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.21 | $0.80 |
| 52 Week High | $7.07 | $3.44 |
| Indicator | SLNG | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 50.41 | 51.91 |
| Support Level | $3.45 | $2.67 |
| Resistance Level | $5.61 | $3.25 |
| Average True Range (ATR) | 0.47 | 0.21 |
| MACD | -0.05 | -0.04 |
| Stochastic Oscillator | 28.60 | 36.29 |
Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. The company has a geographical presence in the United States and Mexico.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.